Evaluation of TEWL (Trans Epidermal Water Loss) in Diabetic Patients
Not Applicable
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2021/07/034575
- Lead Sponsor
- AIIMSRishikesh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Applicable
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All patients with diagnosed Diabetes Mellitus
Exclusion Criteria
Patients with a healed or active Diabetic Foot Ulcer
Patients who have had surgery for DFU
Patients who have had previous surgical intervention in the foot for reasons other than DM
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 2 year/Development of diabetic ulcerTimepoint: Base line, 8 weeks, 16 weeks, 24 weeks, 32 weeks, 40 weeks, 48 weeks
- Secondary Outcome Measures
Name Time Method Measurement value of TEWL in various pressure areas of footTimepoint: Every eight weeks